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1. Introduction 
A classification based on infection as the principal etiology of periodontal diseases divides 
categories based on gingival inflammation and periodontal attachment loss and 
recognized health, gingivitis and periodontitis as separate entities (Armitage 1999). 
Separation of gingivitis from periodontitis suggests that there are differences in these 
conditions that might include type or severity of infection, and/or adequacy of host 
response. Data shows that gingivitis in adults can remain stable throughout many years 
and not endanger the life of the dentition, whereas periodontitis, despite extensive, 
continues to break down the surrounding hard and soft tissue, leading ultimately to tooth 
loss (Seymour 1987). 
Bacterial biofilms have been shown to be the primary etiological factor in the initiation of 
gingival inflammation and subsequent destruction of periodontal tissues (Haffaje & 
Socransky 1994). Although chronic bacterial and endotoxin exposure is a prerequisite for 
gingival inflammation and periodontal tissue destruction to occur, its presence alone 
accounts for a relatively small proportion (i.e. 20%) of the variance in disease expression and 
is not enough to explain the (Grossi et al. 1994). 
2. Bacterial specificities 
An attractive hypothesis concerning the role played by Toll Like Receptors (TLRs) in the 
activation of adaptive immunity holds that the precise combination of TLRs activated by a 
given microbial infection leads to “tailoring” the adaptive immune response so that it can 
deal with that specific infection (Hoebe & Ulevitch 2003). Hence, dendritic cells-stimulated, 
stimulated by LPS, might direct the development of an adaptive response that is better 
suited for dealing with Gram-negative organisms than Gram-positive organisms. When the 
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ability of various oral bacteria to induce innate immune responses from gingival epithelial 
cells is investigated, the results show that non-periodontopathic and orange-complex 
bacteria induce weak and strong responses, respectively, but that red-complex bacteria 
suppress immune responses, live and lysed bacteria showed a difference in their ability to 
induce immune responses from epithelial cells (Ji et al. 2007). The down-regulation of 
interleukin-8 by Porphyromonas gingivalis in both mRNA and protein levels, the so-called 
“chemokine paralysis”, has been well characterized (Darveau et al. 1998).  
It has been controversial whether oral epithelial cells express TLRs (Asai et al. 2001), in 
relation to their apparent unresponsiveness to various microbial products in terms of 
proinflammatory cytokines products. Recently, the authors demonstrated, by 
immunohistochemical analysis the clear expression of NOD1 and NOD2 in normal oral 
epithelial tissues, and also showed, using PCR, flow cytometry, and immunostaining, that 
primary oral epithelial cells in culture expressed these molecules (Sugawara et al. 2006). On 
the other hand, gingival fibroblasts constitutively expressed proinflammatory cytokines. 
Upon stimulation, with chemically synthesized ligands mimicking microbial products for 
the receptors in gingival fibroblast, the production of pro-inflammatory cytokines, such IL-1, 
IL-6, IL-8 and MCP-1 was markedly up regulated (Uehara et al. 2007). In other study, viable 
P. gingivalis induced a strong in vitro inflammatory response in both gingival and 
periodontal ligament fibroblasts incremented gene expression of interleukin (IL)-1, IL-6, IL-
8, TNF- and secreted RANTES (Scheres et al. 2010). These findings indicate that these 
innate immunity-related molecules in gingival fibroblasts are functional receptors involved 
in inflammatory reactions in periodontal tissue, which might be responsible for periodontal 
pathogenesis. 
P. gingivalis, a Gram-negative, anaerobic oral black-pigmented rod, is suspected to be a 
periodontopathic bacterium and has been frequently isolated from the periodontal pockets 
of patients with periodontal diseases (Slots & Listgarten 1988), and the virulence of P. 
gingivalis has been attributed to a variety of factors, including hemagglutinins, cysteine 
proteinases, and fimbriae (Lamont & Jenkinson 1998). Although fimbriae function as a 
colonization factor (Lamont & Jenkinson 1998), evidence suggests that their virulence role 
may extend to immunomodulation of the macrophage response to P. gingivalis, through 
coordinated interaction with pattern-recognition receptors (Hajishengallis et al. 2006). 
Recently, a study demonstrated that P. gingivalis expressing wild-type fimbriae may exploit 
the TLR2/complement receptor 3 pathway for intracellular entry, and persisting in 
macrophages and by reducing the production of IL-12p70, which may facilitate the survival 
of other microbes that cohabit its niche in the oral biofilm (Wang et al. 2007). These results 
support the concept that pathogens evolved to manipulate innate immunity for promoting 
their adaptive fitness and, consequently, their capacity to cause disease (Finlay & McFadden 
2006). The chemical and biological properties of P. gingivalis LPS and its lipid A are different 
from those of enterobacterial LPS and their lipid A (Ogawa 1994), and different forms of P. 
gingivalis lipid functionally interact with only TLR4 (Sawada et al. 2007). Milward et al. 
(Milward et al. 2007) demonstrated that Fusobacterium nucleatum and Porphyromonas 
gingivalis have differential effects at the molecular level on oral epithelial cells and that their 
differences in activating NF-B nuclear translocation in oral epithelial cells may at least in 
part be responsible for the change in dynamics and kinetics of downstream gene expression. 
Genes encoding for structural components of the cytoskeleton, namely cytokeratins, were 
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detected as being differentially expressed in oral epithelial cells in response to challenge by 
Fusobacterium nucleatum and Porphyromonas gingivalis. It is therefore conceivable that bacteria 
may stimulate alterations in cytokeratin expression to gain entry into the underlying 
gingival tissues.   
Challenge of human gingival epithelial cells with Aggregatibacter (Actinobacillus) 
actinomycetemcomitans has been shown to induce the secretion of several pro-inflammatory 
cytokines (Dongari-Bagtzoglou & Ebersole). A previous focus in research on A. 
actinomycetemcomitans leukotoxin has been on its ability to kill neutrophils, the primary 
defense line against bacteria in the periodontal pocket (Johansson et al. 2000a). Other lines 
of research have associated the presence of A. actinomycetemcomitans with concentrations 
of cytokines. Aggregatibacter (Actinobacillus) actinomycetemcomitans is a facultative 
anaerobic Gram-negative bacterium associated with aggressive periodontitis (Slots and 
Ting 1999). A. Actinomycetemcomitans possesses several different well-studied virulence 
factors, among which the leukotoxin us suggested to play an important role in the 
pathogenicity (Feng & Weinberg). Leukotoxin is assumed to contribute to the severity of 
the periodontal disease by disrupting the local defense mechanisms (Guthmiller et al. 
2001). Macrophages are one of the cell types involved in the local immune response and 
various homeostatic, immunological and inflammatory processes and contribute to 
specific immunity via antigen presentation and release of IL-1; they are the main source of 
IL-1 in inflamed tissues (Dinarello 1996). Recently a study showed that purified 
leukotoxin from A. actinomycetemcomitans activates caspase-1 in human 
monocytes/macrophages in vitro and consequently leads to secretion of bioactive IL-1 
(Kelk et al. 2005). Recently, a study showed that enhanced concentration IL-1 correlated 
with a high proportion of A. actinomycetemcomitans in samples from diseased sites of a 
localized aggressive periodontitis patient infected with a minimally leukotoxic strain of A. 
actinomycetemcomitans. This leukotoxin is the main cause of IL-1 secretion from human 
macrophages exposed to highly as well as minimally leukotoxic strains of A. 
actinomycetemcomitans, may indicate that leukotoxin has the potential to trigger the 
inflammatory response (Kelk et al. 2007).  In a site of inflammation, monocytes are 
recruited from the peripheral circulation and need to pass through the blood vessel wall 
to enter the infected tissues. During this migration and later in the tissue they differentiate 
into macrophages and are primed by inflammatory components from the host (Perregaux 
et al. 2002) and microbial components from the infection (Loesche 1993). If the 
macrophages are exposed to a secondary factor (leukotoxin) that activates caspase-1, the 
level of IL1 secretion from these primed macrophages can be substantial and devastating 
for the tissue (Kelk et al. 2007).  
3. Immune response 
The transition process from gingival health to early inflammatory changes is 
characterized by a local increase in vascular permeability, redness, swelling and by the 
recruitment and activation of polymorphonuclear nutrophils (PMNs) (Delina & Van Dyke 
2000). In the course of this acute phase, several products modulate vasodilatation (e.g. 
bradykinin and prostaglandins), vascular permeability (e.g. histamine and leukotriene) 
and additional recruitment of inflammatory cells through chemotaxis (e.g. complements 
products and chemokines) (Offenbacher 1996). The subsequent immune response starts 
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when antigen-presenting cells become involved, presenting the foreign microorganisms or 
antigens to immunocompetent cells such as T lymphocytes. This leads to the expansion of 
antibody-secreting plasma cells and the development of a chronic lesion (Gemmel & 
Seymour 1994). 
Based on clinical and immunological findings, the immune response in the stable gingivitis 
lesion is dependent on proinflammatory reactivity in progressive periodontitis lesion. For 
inflammatory mediators, IL-1, interferon (IFN)- and receptor activator of nuclear factor 
(NF)-B ligand tended to be higher in periodontitis, whereas tumor necrosis factor (TNF)- 
and IL-12 p40 showed no difference (Honda et al. 2006).  These findings suggest that 
perhaps subtle differences in the balance of cytokines may result in different disease 
expression. 
Anti-microbial peptides produced from mucosal epithelium appear to play pivotal roles in 
the host innate immune defense system in the oral cavity. In particular, human beta-
defensins (hBDs) a cathelicidin-type antimicrobial peptide, LL-37, were reported to kill 
periodontal disease-associated bacteria (Bals 2000). Recent studies using 
immunohistochemistry have demonstrated the expression of hBD-1 and hBD-2 in the 
gingival epithelium (Dale 2002). A variety of bacterial components are reported to induce 
hBD-2 mRNA expression by primary gingival epithelial cell (GEC) cultures (Weinberg et al. 
1998). Recently data revealed that neutrophils expressed only LL-37, but not hBD-2 or hBD-
3, and that such expression was prominent in the inflammatory lesions when compared to 
healthy gingival which showed very few or no LL-37 expressing neutrophils. GEC, 
however, expressed al three examined anti-microbial peptides, irrespective of the presence 
or absence of inflammation. Moreover, as determined by ELISA, the concentration of LL-37 
in the gingival tissue homogenates correlated positively with the depth of the gingival 
crevice (Hosokawa et al. 2006). 
3.1 Polymorphonuclear neutrophils 
PMN play an important role in protection of host against invading bacteria during 
gingivitis. In fact, histopathology features of the gingivitis lesions show that PMN are 
prominent within the gingival tissues. Abundant neutrophils have been found within the 
connective tissue, junctional epithelium, and gingival crevice (Schroeder 1970; Attström 
1971). On the other hand, absence or severe impairment of their functions results in an 
increased susceptibility to bacterial infection and some patients with severe peripheral blood 
PMN defects suffer from unusual gingivitis and destructive periodontal diseases (Ryder 
2010). 
PMN perform a complex series of functions during inflammatory response against bacteria: 
(1) adherence, required for subsequent functions performed by PMN at the inflammatory 
site, (2) directed migration towards chemotactic gradients, to reach the inflammatory site, (3) 
expression of receptors for both IgG and C3b on the cell surface, for the ingestion of 
opsonized bacteria, (4) phagocytosis, which is necessary for the clearance of pathogens, (5) 
release of the contents of specific granules, which is important in the regulation of 
themselves and other immune cells, and (5) production of antimicrobial substances. 
Delivery of antimicrobial substances by PMNN is essential to control the bacterial targets 
and it is performed using different mechanisms: (1) Synthesis of oxygen metabolites: When 
PMNN contact certain stimuli (such as opsonized bacteria or chemoattractants) consume 
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dioxygen through a process called respiratory burst and, by transferring 1 or 2 electrons 
from cytosolic NADPH to the extracellular dioxygen via the NADPH oxidase system, form 
toxic superoxide anion (O2-) and hydrogen peroxide (H2O2), respectively (Shapira et al. 1991; 
Ryder 2010). (2) Discharge of lysosomes and secretion: Antimicrobial product secretion by 
movilization of cytoplasmic granules called lysosomes, fusion between the lysosomes and 
phagosomal or plasma membrane, and discharge of granule contents into the phagosome or 
the external environment. (3) Phagocytosis: Implied the engulfment of particles or bacteria 
and their components within a phagosome. Fusion between lysosomes and phagosome 
form the phagolysosome, which bacteria destruction by delivered antibacterial substances at 
a very high concentration by intraphagolysosomal secretion and respiratory burst activity. 
(4) Death: Cytosolic and granule component can be delivered by apoptotic or cytolytic 
mechanisms.       
3.2 Cytokines 
The immune system is alerted to the presence of a pathogen through the activation of the 
innate immune system. The message is transmitted to the cells of the adaptive immunity 
through activated antigen-presenting cells. The development of specific immunity capable 
of eliminating the pathogen is orchestrated by cytokines and chemokines produced by the 
innate system. Cytokines mediate a variety of biological functions, and the network in 
which they act is essential (Bendtzen 1994). They act in the initiation of the effectors phase 
and regulate the length and extent of the response. Initially, cytokines were believed to be 
produced exclusively by CD4 T cells (Abbas et al. 1996), but now is clear that the 
arrangements of cytokines produced by cells is a result of their function and not of their 
phenotype (O’Garra 1998). Furthermore, cytokine production is related to the cells 
differentiation stage and to transitory phases of their response (O’Garra 1998). Considerable 
effort has been made to study the cytokine released by different host cells when exposed to 
components of periodontopathogenic bacteria  (Offenbacher 1996). These studies have 
demonstrated that a number of pro-inflammatory cytokines are synthesized in response to 
periodontopathogenic bacteria and their products, hence inducing and maintaining an 
inflammatory response in the periodontium (Page 1991). 
IL-1 is a multifunctional inflammatory mediator able to modulate bone resorption by the 
activation of osteoclasts (Dewhirst et al. 1985) and by stimulating prostaglandin E2 synthesis 
(Tatakis et al. 1988). Although this cytokine was originally considered to be a product of 
mononuclear phagocytes, evidence suggested that both keratinocytes and gingival 
fibroblasts could also produce it, in response to stimulation by bacterial products (Dinarello 
1998). Data indicate that the local production of IL-1, in the gingival crevicular fluid, 
increases with increasing inflammation (Orozco et al.  2006). The levels of IL-1 are 
increased significantly in sites belonging to the adults periodontitis and early onset 
periodontitis (EOP) patients, compared to those belonging to the healthy and gingivitis 
groups (Giannopoulou et al.  2003; Girolomoni et al. 2002). Marked differences of IL-1 were 
observed in the different disease categories groups, as compared to the healthy group; a 3-
fold increase was noticed in the gingivitis patients, a 6-fold increase in the adults 
periodontitis patients and an almost 9-fold increase in the EOP group. The IL-1 family 
consists of two proteins with similar biologic activities, IL-1 and IL-1, as well as the IL-1 
receptor antagonist (IL-1Ra), a non-signaling ligand. These ligands bind of two distinct and 
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separate receptors, the IL-1 receptor type I (IL-RI) and IL-1RII, respectively, which are 
expressed on a variety of cells and the binding of IL-1 and IL-1 to IL-1RI leads to cellular 
signaling and biologic effects but the binding of IL-1 and IL-1 to IL-1RII does not lead to 
cellular signaling (Dinarello 1998).  
IL-6 is a pleiotropic cytokine that stimulates immunoglobulin secretion by human B-
lymphocytes, activates T cells, stimulates the synthesis and secretion of acute phase proteins 
by hepatocytes, and activates the complement cascade (Revel 1999). The results showed that 
IL-6 is augmented in adult’s periodontitis and EOP when is compared with to the healthy 
and gingivitis groups; the levels IL-6 in the healthy and gingivitis groups was extremely 
low, but showed a 2-fold and 7-fold increase in the adult and EOP groups  (Giannopoulou et 
al. 2003).  
3.3 T and B cells 
Studies in chronic periodontitis using and immunofluorescence support the concept that T 
lymphocytes dominate the cellular infiltrate in healthy/gingivitis lesions, while 
periodontitis lesions are associated with high numbers of B cells in the inflammatory 
infiltrate (Seymour & Greenspan 1979; Berglund et al. 2002). Several studies revealed no 
statistically significant difference between the aggressive periodontitis or early onset 
periodontitis and chronic or adults periodontitis groups and healthy controls with regard to 
the relative counts of B-cells, T-cells, T-helper, T-cytotoxic/suppressor, activated T-cells and 
NK cells (Budunelli et al. 2001; Emingil et al. 2001; Takahashi et al. 1995). In aggressive 
periodontitis, existed a low number of T cells (CD3+) compared to healthy/gingivitis 
biopsies and this reduction of CD3+ could indicate that other lymphocytic cells like B 
lymphocytes may play an important role in the immune response that mediates damage in 
aggressive periodontitis (Suarez et al. 2004).  
T cells are present in the inflammatory infiltrates of periodontal disease lesions and require 
antigen presentation by antigen-presenting cells (APCs). The presence of numerous CD1a+ 
Langerhans cells was noted in the epithelium with no difference between the 
healthy/gingivitis and periodontitis group (Gemmell et al. 2003). Five times as many CD1a+ 
Langerhans cells have been shown in clinically inflamed gingival epithelium compared with 
numbers in the same patients following periodontal treatment (DiFranco 1985). 
While T cells exhibit immunoregulatory features via T-helper 1 and T-helper 2 subsets, B 
cells upon activation transform into antibody producing plasma cells. Polyclonal B-cell 
activation is believed to be of major significance in the development of B-cell lesions (Tew et 
al. 1989). Yamazaki et al. showed that the frequency of B-cells and activated B-cells in the 
periodontitis was much higher than that of gingivitis lesions, suggest that the periodontal 
lesions is also dominated by B cells in the tissue (Yamazaki et al. 1993,28). This was 
substantiated by the results of Afar et al., who demonstrated a marked increase in a B-cell 
subpopulation –namely the autoantibody-producing CD20+ CD5+ cells- of patients with 
periodontitis (Afar et al. 1992). The results of CD40L expression, in the gingival tissue of 
periodontitis patients, suggest that , CD40L-expressing activated T cells stimulate B cells by 
cross-linking CD40 molecules to proliferate and differentiate to plasma cells and subsequent 
immunoglobulin production (Orima et al. 1999). 
3.4 Matrix metalloproteinases (MMPs) in gingivitis 
Extracellular proteolysis and remodeling of the extracellular matrix from periodontal tissues 
is an integral feature of periodontal homeostasis involving a tight balance among protease 
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activities and inhibition. Matrix metalloproteinase’s (MMPs) are genetically distinct but 
structurally related zinc-dependent metalloendopeptidases, described almost fifty years ago 
(Gross and Lapiere, 1962). MMPs can synergistically degrade almost all extracellular matrix 
and basement membrane components and regulate several cellular processes including 
inflammatory responses, representing the most prominent and widely studied family of 
proteinases associated with periodontal diseases (Folgueras et al., 2004; Overall, 2002; Sorsa 
et al., 2006).  
Type I collagen is the major extracellular matrix component of connective periodontal 
tissues setting collagenolytic MMPs among the most prominent mediators and biomarker 
candidates for periodontal tissue breakdown (Golub et al., 1997; Kiili et al., 2002; Rodan and 
Martin, 2000). Since their discovery, collagenolytic MMPs were promptly identified in 
gingival (Geiger and Harper, 1980; Gibson and Fullmer, 1966) and gingival crevicular fluid 
(GCF) (Golub et al., 1976) in association with the degree of gingival inflammation (Overall 
and Sodek, 1987). So far, a burst of evidence supports that collagenases along with other 
MMPs play a pivotal role in periodontal tissue destruction (Sorsa et al., 2006). 
The major collagenolytic MMPs associated with severity of periodontal inflammation and 
disease are MMP-8 and MMP-13. MMP-2 and MMP-9 belong to the gelatinase family of 
MMPs that further degrade denatured collagen basement membranes, among other 
substrates. Whereas MMP-2 expression is constitutive, MMP-9 is strongly induced during 
inflammatory conditions (Kiili et al., 2002; Sorsa et al., 1988; Sorsa et al., 2006; Tervahartiala 
et al., 2000; Uitto et al., 2003). 
MMP-8 and MMP-9 are by far the predominant MMPs in GCF and their major source are 
regarded to be neutrophils, monocytes and macrophages, although resident periodontal 
cells can also produce these MMPs. MMP-9 has also been detected in junctional sulcular and 
pocket gingival epithelial cells and thus it might be involved in epithelial response during 
periodontitis (Smith et al., 2004). Increasing of MMP-8 and MMP-9 are substantially 
involved in chronic periodontitis (Hernandez et al., 2010; Hernandez Rios et al., 2009; Pozo 
et al., 2005) and represent the most promising biomarkers for periodontal inflammation and 
disease severity (Sorsa et al., 2009). Active forms of MMP-8 tend to increase during disease 
progression, whereas neutrophil MMP-8 is the predominant isotype. Nevertheless, 
physiological MMP-8 levels might be required for normal tissue turnover and are thought to 
be rather protective against periodontal destruction (Hernandez et al., 2011; Kuula et al., 
2009).  
MMP-13 on the other hand, is much less abundant in GCF. MMP-13 is expressed by sulcular 
epithelial cells, macrophage-like cells, fibroblasts, plasma cells and osteoblasts (Hernandez 
et al., 2006; Rydziel et al., 2000).  MMP-13 levels are shown to increase in chronic 
periodontitis in comparison to healthy periodontium, whereas MMP-13 increased activity 
has mainly been related to the occurrence of the loss of periodontal supporting tissue and 
alveolar bone resorption. Additionally, MMP-13 can activate proMMP-9 in diseased 
gingival tissue (Hernandez Rios et al., 2009).  
Although a strong body of evidence supports that MMP-8, MMP-9 and MMP-13 play an 
important role in periodontal inflammation and/or supporting tissue loss, few studies have 
focused on the role of these proteinases in gingivitis and reports are somewhat conflicting. 
Previous determinations of MMP -1, -2, -9 and -13 expression through real time-PCR 
showed no differences among gingival samples from healthy, gingivitis and periodontitis 
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subjects, but a tendency for both gelatinases to increase in inflamed tissues (Goncalves et al., 
2008). Conversely, MMP-8 and MMP-9 protein levels, as well as total collagenase activity 
have been found to increase progressively from healthy periodontal tissues and gingivitis to 
periodontitis in GCF and/or saliva samples (Mantyla et al., 2003; Rai et al., 2008; Xu et al., 
2008). Nonetheless, a recent study reported significant increases in GCF IL -1┚ levels along 
with an overall decrease of MMPs in experimental gingivitis model, except for MMP-8. The 
authors also described different subsets of inflammatory phenotypes based on cluster 
analysis of changes in GCF mediators that resulted in a similar clinical phenotype. One of 
the inflammatory phenotypes appeared to be similar to periodontitis, consisting of increases 
in IL-1┙ and IL-1┚, IL-6, MMP-8 and MMP-9, along with a significant decrease in 
macrophage inflammatory protein (MIP)-1┚. This finding suggests that host response 
during gingivitis might be heterogeneous and some of the inflammatory phenotypes could 
be more susceptible to periodontitits development (Offenbacher et al., 2010). Accordingly, 
elevation of active MMP-8 has previously been associated with the conversion of gingivitis 
to periodontitis and established periodontitis (Mantyla et al., 2006). 
Despite MMP-13 has been more related to chronic periodontitis progression than severity 
of inflammation, it has previously been reported that MMP-13 also increase progressively 
from healthy subjects to periodontitis in GCF. Higher levels of active forms and total 
MMP-13 have been described in gingivitis versus healthy sites; whereas MMP-13 levels 
and active forms were significantly higher in chronic periodontitis, compared to both, 
healthy and gingivitis subjects (Ilgenli et al., 2006). Furthermore, chronic periodontitis 
subjects show higher MMP-13 activity in active sites compared to inactive sites and 
healthy controls.  
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